SNDX Sale Disclosure
Podlesak Dennis · SEC Form 4 · Filed Oct 30, 2026
Sale
Calculated transaction value
$113.72K
Podlesak Dennis Director
SNDX
Transaction date
Oct 29, 2026
Public filing date
Oct 30, 2026
Filing lag
Filed 1 day later
SNDX daily price context
Close on/before transaction
$14.15
Oct 29, 2026
First close after public filing
$13.1
Nov 2, 2026
Return after filing · so far
-27.18%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 8,000 shares @ $14.21
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-442119
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$208.2K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Syndax Pharmaceuticals Inc SNDX | Exercise | Oct 29, 2026 | $0 |
| Syndax Pharmaceuticals Inc SNDX | Exercise | Oct 29, 2026 | $94.48K |
| Syndax Pharmaceuticals Inc SNDX Current | Sale | Oct 29, 2026 | $113.72K |